Healthtech startup Biofourmis secures US$35M Series B funding

The startup, previously based in Singaore, will move its headquarters to Boston

Biofourmis, a digital therapeutics provider, announced that it has closed US$35 million in Series B financing. The company also said it plans to move its headquarters from Singapore to Boston but will continue to expand its activities in Singapore.

The funding was led by Sequoia India, part of Sequoia Capital, and MassMutual Ventures SEA, the venture fund of Massachusetts Mutual Life Insurance Company (

What feeling does this article give you?

#hashtags to follow:

Singaore [+]    Boston [+]    Biofourmis [+]    Singapore [+]    Sequoia India [+]    Sequoia Capital [+]    MassMutual Ventures SEA [+]   

More #news: